BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

731 related articles for article (PubMed ID: 9070359)

  • 1. Cloning, sequencing, and recombinant expression of NAT1, NAT2, and NAT3 derived from the C3H/HeJ (rapid) and A/HeJ (slow) acetylator inbred mouse: functional characterization of the activation and deactivation of aromatic amine carcinogens.
    Fretland AJ; Doll MA; Gray K; Feng Y; Hein DW
    Toxicol Appl Pharmacol; 1997 Feb; 142(2):360-6. PubMed ID: 9070359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Syrian hamster monomorphic N-acetyltransferase (NAT1) alleles: amplification, cloning, sequencing, and expression in E. coli.
    Ferguson RJ; Doll MA; Rustan TD; Baumstark BR; Hein DW
    Pharmacogenetics; 1994 Apr; 4(2):82-90. PubMed ID: 8081415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic activation of N-hydroxy-2-aminofluorene and N-hydroxy-2-acetylaminofluorene by monomorphic N-acetyltransferase (NAT1) and polymorphic N-acetyltransferase (NAT2) in colon cytosols of Syrian hamsters congenic at the NAT2 locus.
    Hein DW; Doll MA; Gray K; Rustan TD; Ferguson RJ
    Cancer Res; 1993 Feb; 53(3):509-14. PubMed ID: 8425184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monomorphic and polymorphic human arylamine N-acetyltransferases: a comparison of liver isozymes and expressed products of two cloned genes.
    Grant DM; Blum M; Beer M; Meyer UA
    Mol Pharmacol; 1991 Feb; 39(2):184-91. PubMed ID: 1996083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of arylamine acetyltransferase Nat3 gene knockout on N-acetylation in the mouse.
    Sugamori KS; Brenneman D; Wong S; Gaedigk A; Yu V; Abramovici H; Rozmahel R; Grant DM
    Drug Metab Dispos; 2007 Jul; 35(7):1064-70. PubMed ID: 17403913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 4-Aminobiphenyl downregulation of NAT2 acetylator genotype-dependent N- and O-acetylation of aromatic and heterocyclic amine carcinogens in primary mammary epithelial cell cultures from rapid and slow acetylator rats.
    Jefferson FA; Xiao GH; Hein DW
    Toxicol Sci; 2009 Jan; 107(1):293-7. PubMed ID: 18842621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic activation of N-hydroxyarylamines and N-hydroxyarylamides by 16 recombinant human NAT2 allozymes: effects of 7 specific NAT2 nucleic acid substitutions.
    Hein DW; Doll MA; Rustan TD; Ferguson RJ
    Cancer Res; 1995 Aug; 55(16):3531-6. PubMed ID: 7627960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction of Syrian hamster lines congenic at the polymorphic acetyltransferase locus (NAT2): acetylator genotype-dependent N- and O-acetylation of arylamine carcinogens.
    Hein DW; Doll MA; Rustan TD; Gray K; Ferguson RJ; Feng Y
    Toxicol Appl Pharmacol; 1994 Jan; 124(1):16-24. PubMed ID: 8291057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cloning, expression, and functional characterization of two mutant (NAT2(191) and NAT2(341/803)) and wild-type human polymorphic N-acetyltransferase (NAT2) alleles.
    Ferguson RJ; Doll MA; Rustan TD; Gray K; Hein DW
    Drug Metab Dispos; 1994; 22(3):371-6. PubMed ID: 7915226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases.
    Hein DW; Doll MA; Rustan TD; Gray K; Feng Y; Ferguson RJ; Grant DM
    Carcinogenesis; 1993 Aug; 14(8):1633-8. PubMed ID: 8353847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cloning, expression, and functional characterization of rapid and slow acetylator polymorphic N-acetyl-transferase encoding genes of the Syrian hamster.
    Ferguson RJ; Doll MA; Rustan TD; Hein DW
    Pharmacogenetics; 1996 Feb; 6(1):55-66. PubMed ID: 8845861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a novel allele at the human NAT1 acetyltransferase locus.
    Doll MA; Jiang W; Deitz AC; Rustan TD; Hein DW
    Biochem Biophys Res Commun; 1997 Apr; 233(3):584-91. PubMed ID: 9168895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and characterization of functional rat arylamine N-acetyltransferase 3: comparisons with rat arylamine N-acetyltransferases 1 and 2.
    Walraven JM; Doll MA; Hein DW
    J Pharmacol Exp Ther; 2006 Oct; 319(1):369-75. PubMed ID: 16829624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular genetic basis of rapid and slow acetylation in mice.
    Martell KJ; Vatsis KP; Weber WW
    Mol Pharmacol; 1991 Aug; 40(2):218-27. PubMed ID: 1875909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isoform-selective inactivation of human arylamine N-acetyltransferases by reactive metabolites of carcinogenic arylamines.
    Liu L; Wagner CR; Hanna PE
    Chem Res Toxicol; 2009 Dec; 22(12):1962-74. PubMed ID: 19842618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Higher frequency of aberrant crypt foci in rapid than slow acetylator inbred rats administered the colon carcinogen 3,2'-dimethyl-4-aminobiphenyl.
    Feng Y; Fretland AJ; Rustan TD; Jiang W; Becker WK; Hein DW
    Toxicol Appl Pharmacol; 1997 Nov; 147(1):56-62. PubMed ID: 9356307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue distribution of N-acetyltransferase 1 and 2 catalyzing the N-acetylation of 4-aminobiphenyl and O-acetylation of N-hydroxy-4-aminobiphenyl in the congenic rapid and slow acetylator Syrian hamster.
    Hein DW; Doll MA; Nerland DE; Fretland AJ
    Mol Carcinog; 2006 Apr; 45(4):230-8. PubMed ID: 16482518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification of hepatic polymorphic arylamine N-acetyltransferase from homozygous rapid acetylator inbred hamster: identity with polymorphic N-hydroxyarylamine-O-acetyltransferase.
    Trinidad A; Hein DW; Rustan TD; Ferguson RJ; Miller LS; Bucher KD; Kirlin WG; Ogolla F; Andrews AF
    Cancer Res; 1990 Dec; 50(24):7942-9. PubMed ID: 2253236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms.
    Hein DW; Doll MA; Fretland AJ; Leff MA; Webb SJ; Xiao GH; Devanaboyina US; Nangju NA; Feng Y
    Cancer Epidemiol Biomarkers Prev; 2000 Jan; 9(1):29-42. PubMed ID: 10667461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catalytic properties and heat stabilities of novel recombinant human N-acetyltransferase 2 allozymes support existence of genetic heterogeneity within the slow acetylator phenotype.
    Hein DW; Doll MA
    Arch Toxicol; 2017 Aug; 91(8):2827-2835. PubMed ID: 28523442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.